Structural and biological analyses of these new analogues, coupled with the further exploration of diverse structures could help guide the development of new PET tracers and identify a suitable PET tracer for imaging α-synuclein in PD and other related diseases. The gene discussed is SNCA; the disease is Parkinson disease.